Last updated on October 2017

Intravesicular Onabotulinumtoxin A in Interstitial Cystitis


Brief description of study

The purpose of this research study is to identify the optimal usage of Onabotulinumtoxin A in interstitial cystitis. Onabotulinumtoxin A, more commonly known by the trade name Botox®, is a medication that comes from the bacteria Clostridium botulinum. It works by blocking the release of the neurotransmitter acetylcholine(a chemical messenger that carries signals between nerve cells and other cells in the body). Blocking that neurotransmitter results in decreased muscle activity.

Detailed Study Description

The purpose of this study is to evaluate the efficacy of intravesicular Onabotulinumtoxin A injections for the treatment of interstitial cystitis (IC). Specifically, we hypothesize that trigonal Onabotulinumtoxin A injections is an effective treatment for IC and will result in more subjective and objective symptom relief than posterior wall Onabotulinumtoxin A injections.

Clinical Study Identifier: NCT02297100

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Robert J Evans, M.D.

Wake Forest School of Medicine
Winston-Salem, NC United States
  Connect »